Amoxicillin And Clavulanate Potassium
Product Images NDC 68071-2431

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Amoxicillin And Clavulanate Potassium (NDC 68071-2431). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 2431 1)

Pdp (68071 2431 1)
Amoxicillin and Clavulanate Potassium 875mg/125mg tablets package label from NuCare Pharmaceuticals, Inc. The label states each tablet contains 875mg Amoxicillin and 125mg Clavulanic Acid as Clavulanate Potassium in a scored, debossed white tablet form. The package contains 10 tablets, with product number P0712010 and instructions to store at controlled temperature 68-77°F. It is labeled Rx only.*
FDA Label Image

Table (Clinical Table)

Table (Clinical Table)
A data table titled 'Bacteriologic efficacy rates for AUGMENTIN' showing efficacy percentages and sample sizes for two dosing regimens: 875 mg every 12 hours and 500 mg every 8 hours, across three time intervals post therapy: 2 to 4 days, 5 to 9 days, and 2 to 4 weeks.*
FDA Label Image

Image (Decription Image 1)

Image (Decription Image 1)
Chemical structure of Amoxicillin and Clavulanate Potassium, depicting the molecular composition including the beta-lactam ring, phenol group, and clavulanate moiety with hydrate components.*
FDA Label Image

Image (Decription Image 2)

Image (Decription Image 2)
Chemical structure diagram of amoxicillin, showing its molecular framework including beta-lactam and hydroxyl functional groups.*
FDA Label Image

Image (Dosageand Admini Table1)

Image (Dosageand Admini Table1)
A dosing table for Amoxicillin and Clavulanate Potassium in patients aged 12 weeks (3 months) and older. It details dosing regimens for infections including otitis media, sinusitis, and lower respiratory tract infections with doses given every 12 hours or every 8 hours using oral suspension strengths of 125 mg/5 mL, 200 mg/5 mL, or 250 mg/5 mL. Dosing varies by infection severity and frequency.*
FDA Label Image

Table (Dosageand Admini Table2)

Table (Dosageand Admini Table2)
A data table titled 'Amount of Water for Mixing Oral Suspension' for Amoxicillin and Clavulanate Potassium. It lists various strengths (125 mg/5 mL to 400 mg/5 mL), bottle sizes (ranging from 50 mL to 150 mL), corresponding amounts of water required for reconstitution, and the active content per teaspoonful (5 mL) including amoxicillin and clavulanic acid as potassium salt.*
FDA Label Image

Table (Pharmacokine Table)

Table (Pharmacokine Table)
Data tables presenting mean pharmacokinetic parameters (Cmax and AUC0-24) for Amoxicillin and Clavulanate Potassium with AUGMENTIN tablets and oral suspension/chewable tablets. The tables include dosage regimens and corresponding drug concentrations in mcg/mL for Amoxicillin and Clavulanate Potassium, with notes on administration and subject numbers.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.